Final ID: Sa3012
Fujioka Tomoo, Iino Takuya, Toh Ryuji, Harada Amane, Nagao Manabu, Shinohara Masakazu, Ishida Tatsuro, Otake Hiromasa
ALPACAR Phase 2 Trial of Zerlasiran: Multiple doses of a Small-Interfering RNA Targeting Lipoprotein(a) with 60 weeks Folow Up.Nissen Steven, Dorresteijn Jannick, Fok Henry, Rider David, Romano Steve, Wolski Kathy, Rambaran Curtis, Wang Qiuqing, Nicholls Stephen, Navar Ann Marie, Ray Kausik, Schwartz Gregory, Szarek Michael, Stroes Erik, Troquay Roland